Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- PrEParing for the next phase of COVID-19: Protective layers for immunocompromised patients Rob Volansky
-
- ACR praises bipartisan letter urging US House leaders to avert impending 'Medicare cliff' Jason Laday
- Upadacitinib improves signs, symptoms of ankylosing spondylitis, nonradiographic axSpA Jason Laday
- #ACR21 postscript: Attending meetings is easier ‘away from home’ Leonard H. Calabrese, DO
- COVID-19 vaccines for young children with rheumatic diseases: What providers need to know Jason Laday
- Hooked on Rheum with Jinoos Yazdany, MD, MPH Jinoos Yazdany, MD, MPH
- Ankylosing spondylitis incidence similar among men, women in study of US Army veterans Jason Laday
- EULAR: Tocilizumab plus glucocorticoids benefits COVID-19 cases requiring oxygen Jason Laday
- Plasma osteopontin may offer 'reliable biomarker' to predict COVID-19, MIS-C severity Jason Laday
-
- 'Advanced vascular imaging' drives revision to ACR/EULAR vasculitis classification criteria Rob Volansky
- 'Back to normal': Fixing failures of pre-COVID status quo requires 'radical shift' Jason Laday
- B-cell therapies, mycophenolate worsen COVID-19 vaccine response in inflammatory disease Robert Stott
- COVID-19 vaccine response in patients with lupus ‘blunted’ by immunosuppressant use Robert Stott
- Great Debate pits belimumab against voclosporin as first-line therapy for lupus nephritis Rob Volansky
- No link between mRNA COVID-19 vaccines and increased flare risk in rheumatic disease Rob Volansky
- Cardiovascular benefits from statins outweigh diabetes risk in patients with RA Stacey L. Adams
- Vitamin D, omega-3 supplements reduced risk for incident autoimmune disease Jason Laday
-
- Breakthrough COVID-19 in vaccinated patients linked to B-cell therapies, mycophenolate Rob Volansky